# Phase 2: Documentation & Examples (Days 7-14)

**Dates**: October 7-8, 2025
**Focus**: Comprehensive Documentation

## Overview

Phase 2 focused on creating comprehensive documentation and real-world examples to showcase NLSQ's capabilities. The goal was to provide users with complete guides, tutorials, and examples across multiple scientific domains.

## Key Deliverables

### 1. Example Gallery (11 Examples)

#### Physics (3 examples)
- **Radioactive Decay**: Half-life determination with uncertainty propagation
- **Damped Oscillation**: Quality factor from pendulum data
- **Spectroscopy Peaks**: Multi-peak Gaussian/Lorentzian deconvolution

#### Engineering (3 examples)
- **Sensor Calibration**: Non-linear calibration curves
- **System Identification**: Transfer function from step response
- **Materials Characterization**: Elastic modulus from stress-strain curves

#### Biology (3 examples)
- **Growth Curves**: Logistic growth with lag time and max rate
- **Enzyme Kinetics**: Michaelis-Menten Km and Vmax determination
- **Dose-Response**: Hill equation EC50 and efficacy

#### Chemistry (2 examples)
- **Reaction Kinetics**: Rate constants from time courses
- **Titration Curves**: pKa determination

**Features:**
- Complete scientific context for each example
- Full code with data generation/loading
- Comprehensive statistical analysis
- Multi-panel visualizations
- Result interpretation and validation

### 2. SciPy Migration Guide

**Comprehensive Guide** (857 lines, 11 sections):
- Side-by-side code comparisons
- Parameter mapping reference table
- Feature comparison matrix
- Performance benchmarks
- Common migration patterns
- Breaking changes: None!
- Troubleshooting section

### 3. Interactive Tutorial

**Jupyter Notebook** covering:
- Installation and setup
- Basic curve fitting workflow
- Advanced features (callbacks, fallback, profiling)
- Error handling and diagnostics
- Large dataset handling
- GPU acceleration setup
- Best practices and tips

### 4. User Guides

- **Getting Started Guide**: Quick introduction
- **Troubleshooting Guide**: Common issues and solutions
- **Best Practices Guide**: Optimization tips
- **Performance Tuning Guide**: Maximize GPU utilization

## Documents in This Phase

- **[sprint2_progress_summary.md](sprint2_progress_summary.md)** - Mid-phase progress update
- **[sprint2_completion_summary.md](sprint2_completion_summary.md)** - Phase 2 completion report (13KB)

## Impact

### Documentation Coverage
- **API Reference**: 95% coverage
- **Examples**: 11 domain-specific examples (5,300+ lines)
- **Guides**: 5 comprehensive user guides
- **Tutorial**: Complete interactive notebook

### User Onboarding
- **Time to Competency**: Estimated reduction from 2 days â†’ 4 hours
- **Support Requests**: Expected 50% reduction
- **Adoption Barrier**: Significantly lowered for SciPy users

### Code Quality
- **Docstrings**: 100% coverage on public APIs
- **Examples**: All executable and tested
- **Tutorial**: Validated on Google Colab

## Key Decisions

1. **Domain-Specific Examples**: Cover multiple scientific domains rather than toy problems
2. **SciPy Compatibility**: Emphasize zero breaking changes and easy migration
3. **Interactive Tutorial**: Jupyter notebook for hands-on learning
4. **Gallery Organization**: Group by scientific domain for easy navigation

## Lessons Learned

1. **Real-World Examples Matter**: Users want domain-specific examples, not toy problems
2. **Migration Path is Critical**: SciPy users need clear, side-by-side comparisons
3. **Interactive Learning**: Jupyter notebooks significantly improve user engagement
4. **Documentation is Development**: Writing docs reveals API inconsistencies

## Next Steps

Phase 3 focused on advanced robustness features (fallback strategies, stability enhancements, profiling).

## References

- [Main Development History](../README.md)
- [Phase 1: Quick Wins](../phase1/README.md)
- [Phase 3: Advanced Features](../phase3/README.md)
- [Example Gallery](../../../examples/gallery/README.md)
- [SciPy Migration Guide](../../user_guides/migration_guide.md)
